Clinical Trial Update: PSUNRISE - Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating infliximab (Remicade) in psoriasis patients with an inadequate response to etanercept; the study has completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Etanercept (etanercept)
• Remicade (infliximab)

Snippet

Sponsor: Centocor Ortho Biotech Services, L.L.C. | Conditions: Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2010-06-24